- Biotechnology
- Wednesday, 24 Jun 2020
Philogen Received Combination Pack Approval for Nidlegy
Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, on Jan. 30, 2020, EMA's CHMP expressed a favorable opinion to the request of a combination pack for the to-be-marketed pharmaceutical form of NidlegyTM, a combination of the active principles bifikafusp alfa (L19IL2) and onfekafusp alfa (L19TNF). NidlegyTM is being developed as a neoadjuvant intralesional treatment for resectable Stage III melanoma patients and in locally advanced, not metastatic nonmelanoma skin cancers. NidlegyTM combination pack has now received confirmation of eligibility to the centralized procedure for submission of an application for a Union Marketing Authorisation under Article 3(1) - Indent 1 - Biotech medicinal product of Regulation (EC) No 726/2004.
"We are extremely pleased to record EMA's agreement to our strategy for the marketing of NidlegyTM as a combination pack that was considered by CHMP 'indispensable for public health reasons,'" commented Prof. Dario Neri, co-founder and President of the Scientific Advisory Board of Philogen.
Related Industry Updates
Poultry Diagnostics Market is expected to reach US$ 792.70 million by 2030
Sep 20, 2023
Biopharmaceuticals Contract Manufacturing Market Outlook to 2027 - WuXi Biologics, General Electric, Samsung Biologics, Merck KGaA
Apr 30, 2020
Peripheral Vascular Devices Market Pegged for Robust Expansion by 2027
Nov 30, 2020
Synbiotic Market Complete Survey 2020-2027: BIOMIN Holding GmbH, Daflorn Ltd., Danone S.A., Diamond V, General Mills Inc
Apr 23, 2021
Digital X-Ray Market Size 2020 Industry Analysis, Key Players, Growth Prospects, Revenue, Production, New Development, Business Share, Global Trends and Forecast To 2027
Jan 07, 2021
North America Gas Cold Compression Therapy Market 2020 Regional Outlook 2027 Covid-19 Overview On Top Companies – Össur Americas,3M,Breg, Inc,Beiersdorf,Performance Health,Thermotek Inc,Bio Compression Systems, Inc,Johnson and Johnson,Unexo Lifesciences,Arjo
Jan 05, 2021
Immunoassay Market Shoots of US$ 37,987.8 Mn by 2027 in World with BD, Danaher Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific Inc, Quidel Corporation
Apr 01, 2021
Follow us on
